CVS Health (CVS) Stock Insights
CVS$90.06-1.07 -1.17%
$115.18B
Market Cap
24.16
P/E
11.19
Forward P/E
47
Score
CVS Health (CVS) Stock Insights
CVS price $90.06 -1.07 -1.17%
- Ticker
- CVS
- Price
- $90.06
- Change
- -1.07 -1.17%
- Market cap ?
- $115.18B
- P/E ?
- 24.16
- Forward P/E ?
- 11.19
- Dividend yield ?
- 2.87%
- Beta ?
- 0.60
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- Stocklytics score
- 47
- Value
- 65
- Quality
- 29
- Growth
- 48
Stocklytics score rationale: value 65, quality 29, growth 48.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 177546000000 | 184786000000 | 194579000000 | 256776000000 | 268706000000 | 292111000000 | 322467000000 | 357776000000 | 372809000000 | 402067000000 |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in…
Fair value
CVS fair value $154.73. Price $90.06. Price is 42% below fair value.
Below fair value, but more expensive than usual. A smaller discount than on 80% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 11.76B. Growth 8.38%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.28B. Net debt 85.08B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | 1.66 | — | 104.72B |
| 2026-08-05 | 2.58 | 1.85 | 106.10B | 100.03B |
| 2026-05-06 | 2.57 | 2.18 | 100.43B | 94.99B |
| 2026-02-10 | 1.09 | 1.00 | 105.69B | 103.70B |
| 2025-10-29 | 1.60 | 1.37 | 102.87B | 98.81B |
| 2025-07-31 | 1.81 | 1.46 | 98.92B | 94.53B |
| 2025-05-01 | 2.25 | 1.70 | 94.59B | 93.68B |
| 2025-02-12 | 1.19 | 0.91 | 97.71B | 97.09B |
| 2024-11-06 | 1.09 | 1.44 | 95.43B | 92.75B |
| 2024-08-07 | 1.83 | 1.73 | 91.23B | 91.41B |
| 2024-05-01 | 1.31 | 1.70 | 88.44B | 89.33B |
| 2024-02-07 | 2.12 | 2.01 | 93.81B | 90.36B |
| 2023-11-01 | 2.21 | 2.13 | 89.76B | 88.25B |
| 2023-08-02 | 2.21 | 2.12 | 88.92B | 86.53B |
| 2023-05-03 | 2.20 | 2.07 | 85.28B | 80.81B |
| 2023-02-08 | 1.99 | 1.92 | 83.85B | 76.43B |
| 2022-11-02 | 2.09 | 1.99 | 81.16B | 76.74B |
| 2022-08-03 | 2.40 | 2.17 | 80.64B | 76.41B |
| 2022-05-04 | 2.22 | 2.15 | 76.83B | 75.54B |
| 2022-02-09 | 1.98 | 1.94 | 76.60B | 75.66B |
| 2021-11-03 | 1.97 | 1.79 | 73.79B | 70.34B |
| 2021-08-04 | 2.42 | 2.06 | 72.62B | 70.30B |
| 2021-05-04 | 2.04 | 1.72 | 69.10B | 68.34B |
| 2021-02-16 | 1.30 | 1.24 | 69.55B | 66.19B |
| 2020-11-06 | 1.66 | 1.34 | 67.06B | 50.42B |
| 2020-08-05 | 2.64 | 1.93 | 65.34B | 47.77B |
| 2020-05-06 | 1.91 | 1.63 | 66.75B | 56.97B |
| 2020-02-12 | 1.73 | 1.68 | 66.89B | 64.96B |
| 2019-11-06 | 1.84 | 1.77 | 64.81B | 62.34B |
| 2019-08-07 | 1.89 | 1.69 | 63.43B | 56.72B |
| 2019-05-01 | 1.62 | 1.50 | 61.65B | 57.08B |
| 2019-02-20 | 2.14 | 2.07 | 54.91B | 52.60B |
| 2018-11-06 | 1.73 | 1.71 | 47.49B | 46.94B |
| 2018-08-08 | 1.69 | 1.61 | 46.92B | 44.70B |
| 2018-05-02 | 1.48 | 1.39 | 45.74B | 43.58B |
| 2018-02-08 | 1.92 | 1.89 | 48.38B | 47.65B |
| 2017-11-06 | 1.50 | 1.48 | 46.18B | 45.87B |
| 2017-08-08 | 1.33 | 1.31 | 45.69B | 45.00B |
| 2017-05-02 | 1.17 | 1.10 | 44.51B | 41.85B |
| 2017-02-09 | 1.71 | 1.67 | 45.97B | 44.92B |
Dividends
Yield 2.95%. Payout ratio 69.63%. Frequency Quarterly.
Safety score 89/100 · Safe. Payout ratio is 70% of earnings. Dividends use less than 40% of free cash flow. Dividends were paid in 42 separate years. Yield is 3.0%, in a range that is usually sustainable.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-10-22 | $0.67 | 2026-10-22 | 2026-11-02 | Quarterly |
| 2026-07-23 | $0.67 | 2026-07-23 | 2026-08-03 | Quarterly |
| 2026-04-23 | $0.67 | 2026-04-23 | 2026-05-04 | Quarterly |
| 2026-01-22 | $0.67 | 2026-01-22 | 2026-02-02 | Quarterly |
| 2025-10-23 | $0.67 | 2025-10-23 | 2025-11-03 | Quarterly |
| 2025-07-22 | $0.67 | 2025-07-22 | 2025-08-01 | Quarterly |
| 2025-04-22 | $0.67 | 2025-04-22 | 2025-05-01 | Quarterly |
| 2025-01-23 | $0.67 | 2025-01-23 | 2025-02-03 | Quarterly |
| 2024-10-21 | $0.67 | 2024-10-21 | 2024-11-01 | Quarterly |
| 2024-07-22 | $0.67 | 2024-07-22 | 2024-08-01 | Quarterly |
| 2024-04-19 | $0.67 | 2024-04-22 | 2024-05-01 | Quarterly |
| 2024-01-19 | $0.67 | 2024-01-22 | 2024-02-01 | Quarterly |
| 2023-10-19 | $0.60 | 2023-10-20 | 2023-11-01 | Quarterly |
| 2023-07-20 | $0.60 | 2023-07-21 | 2023-08-01 | Quarterly |
| 2023-04-20 | $0.60 | 2023-04-21 | 2023-05-01 | Quarterly |
| 2023-01-19 | $0.60 | 2023-01-20 | 2023-02-01 | Quarterly |
| 2022-10-20 | $0.55 | 2022-10-21 | 2022-11-01 | Quarterly |
| 2022-07-21 | $0.55 | 2022-07-22 | 2022-08-01 | Quarterly |
| 2022-04-21 | $0.55 | 2022-04-22 | 2022-05-02 | Quarterly |
| 2022-01-20 | $0.55 | 2022-01-21 | 2022-02-01 | Quarterly |
| 2021-10-21 | $0.50 | 2021-10-22 | 2021-11-01 | Quarterly |
| 2021-07-22 | $0.50 | 2021-07-23 | 2021-08-02 | Quarterly |
| 2021-04-22 | $0.50 | 2021-04-23 | 2021-05-03 | Quarterly |
| 2021-01-21 | $0.50 | 2021-01-22 | 2021-02-01 | Quarterly |
| 2020-10-21 | $0.50 | 2020-10-22 | 2020-11-02 | Quarterly |
| 2020-07-22 | $0.50 | 2020-07-23 | 2020-08-03 | Quarterly |
| 2020-04-22 | $0.50 | 2020-04-23 | 2020-05-04 | Quarterly |
| 2020-01-22 | $0.50 | 2020-01-23 | 2020-02-03 | Quarterly |
| 2019-10-23 | $0.50 | 2019-10-24 | 2019-11-04 | Quarterly |
| 2019-07-24 | $0.50 | 2019-07-25 | 2019-08-02 | Quarterly |
| 2019-04-22 | $0.50 | 2019-04-23 | 2019-05-03 | Quarterly |
| 2019-01-24 | $0.50 | 2019-01-25 | 2019-02-04 | Quarterly |
| 2018-10-23 | $0.50 | 2018-10-24 | 2018-11-01 | Quarterly |
| 2018-07-24 | $0.50 | 2018-07-25 | 2018-08-01 | Quarterly |
| 2018-04-20 | $0.50 | 2018-04-23 | 2018-05-03 | Quarterly |
| 2018-01-23 | $0.50 | 2018-01-24 | 2018-02-02 | Quarterly |
| 2017-10-23 | $0.50 | 2017-10-24 | 2017-11-03 | Quarterly |
| 2017-07-20 | $0.50 | 2017-07-24 | 2017-08-03 | Quarterly |
| 2017-04-19 | $0.50 | 2017-04-21 | 2017-05-01 | Quarterly |
| 2017-01-20 | $0.50 | 2017-01-24 | 2017-02-02 | Quarterly |
| 2016-10-20 | $0.42 | 2016-10-24 | 2016-11-03 | Quarterly |
| 2016-07-19 | $0.42 | 2016-07-21 | 2016-08-01 | Quarterly |
| 2016-04-20 | $0.42 | 2016-04-22 | 2016-05-02 | Quarterly |
| 2016-01-20 | $0.42 | 2016-01-22 | 2016-02-02 | Quarterly |
| 2015-10-20 | $0.35 | 2015-10-22 | 2015-11-02 | Quarterly |
| 2015-07-21 | $0.35 | 2015-07-23 | 2015-08-03 | Quarterly |
| 2015-04-22 | $0.35 | 2015-04-24 | 2015-05-04 | Quarterly |
| 2015-01-20 | $0.35 | 2015-01-22 | 2015-02-02 | Quarterly |
| 2014-10-21 | $0.28 | 2014-10-23 | 2014-11-03 | Quarterly |
| 2014-07-17 | $0.28 | 2014-07-21 | 2014-08-01 | Quarterly |
| 2014-04-17 | $0.28 | 2014-04-22 | 2014-05-02 | Quarterly |
| 2014-01-21 | $0.28 | 2014-01-23 | 2014-02-03 | Quarterly |
| 2013-10-17 | $0.23 | 2013-10-21 | 2013-11-01 | Quarterly |
| 2013-07-18 | $0.23 | 2013-07-22 | 2013-08-02 | Quarterly |
| 2013-04-19 | $0.23 | 2013-04-23 | 2013-05-03 | Quarterly |
| 2013-01-22 | $0.23 | 2013-01-24 | 2013-02-04 | Quarterly |
| 2012-10-18 | $0.16 | 2012-10-22 | 2012-11-02 | Quarterly |
| 2012-07-19 | $0.16 | 2012-07-23 | 2012-08-03 | Quarterly |
| 2012-04-19 | $0.16 | 2012-04-23 | 2012-05-03 | Quarterly |
| 2012-01-19 | $0.16 | 2012-01-23 | 2012-02-02 | Quarterly |
| 2011-10-19 | $0.12 | 2011-10-21 | 2011-11-01 | Quarterly |
| 2011-07-20 | $0.12 | 2011-07-22 | 2011-08-02 | Quarterly |
| 2011-04-19 | $0.12 | 2011-04-22 | 2011-05-03 | Quarterly |
| 2011-01-19 | $0.12 | 2011-01-21 | 2011-02-02 | Quarterly |
| 2010-10-20 | $0.09 | 2010-10-22 | 2010-11-02 | Quarterly |
| 2010-07-20 | $0.09 | 2010-07-22 | 2010-08-02 | Quarterly |
| 2010-04-21 | $0.09 | 2010-04-23 | 2010-05-04 | Quarterly |
| 2010-01-20 | $0.09 | 2010-01-22 | 2010-02-02 | Quarterly |
| 2009-10-20 | $0.08 | 2009-10-22 | 2009-11-03 | Quarterly |
| 2009-07-21 | $0.08 | 2009-07-23 | 2009-08-03 | Quarterly |
| 2009-04-20 | $0.08 | 2009-04-22 | 2009-05-04 | Quarterly |
| 2009-01-21 | $0.08 | 2009-01-23 | 2009-02-03 | Quarterly |
| 2008-10-17 | $0.07 | 2008-10-21 | 2008-11-03 | Quarterly |
| 2008-07-17 | $0.07 | 2008-07-21 | 2008-08-01 | Quarterly |
| 2008-04-17 | $0.06 | 2008-04-21 | 2008-05-02 | Quarterly |
| 2008-01-17 | $0.06 | 2008-01-22 | 2008-02-01 | Quarterly |
| 2007-10-18 | $0.06 | 2007-10-22 | 2007-11-02 | Quarterly |
| 2007-07-19 | $0.06 | 2007-07-23 | 2007-08-03 | Quarterly |
| 2007-04-20 | $0.06 | 2007-04-24 | 2007-05-04 | Quarterly |
| 2007-01-18 | $0.05 | 2007-01-22 | 2007-02-02 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-26 | Clark James David | Sell | 454 | $90.98 | 41.30K |
| 2026-05-31 | Newman Brian | Sell | 2.48K | $90.98 | 225.45K |
| 2026-05-31 | Compton-Phillips Amy | Sell | 7.62K | $90.98 | 693.09K |
| 2026-05-21 | AGUIRRE FERNANDO | Sell | 1.56K | $93.50 | 146.14K |
| 2026-05-21 | ROBBINS LARRY | Sell | 370.46K | $93.45 | 34.62M |
| 2026-05-21 | ROBBINS LARRY | Sell | 378.00K | $58.29 | 22.03M |
| 2026-05-20 | AGUIRRE FERNANDO | Sell | 30.44K | $93.78 | 2.85M |
| 2026-05-20 | ROBBINS LARRY | Sell | 797.63K | $93.48 | 74.56M |
| 2026-05-20 | ROBBINS LARRY | Sell | 152.69K | $94.81 | 14.48M |
| 2026-05-20 | ROBBINS LARRY | Sell | 66.88K | $95.67 | 6.40M |
| 2026-05-20 | ROBBINS LARRY | Sell | 800 | $96.28 | 77.03K |
| 2026-05-19 | ROBBINS LARRY | Sell | 1.98M | $94.45 | 187.33M |
| 2026-05-19 | ROBBINS LARRY | Sell | 151 | $95.18 | 14.37K |
| 2026-05-14 | Gallina John E | Buy | 1.45K | $97.15 | 140.63K |
| 2026-05-14 | Mahoney Michael F | Buy | 1.74K | $97.15 | 168.75K |
| 2026-05-14 | AGUIRRE FERNANDO | Buy | 1.56K | $97.15 | 151.85K |
| 2026-05-14 | Balser Jeffrey R. | Buy | 2.06K | $97.15 | 199.93K |
| 2026-05-14 | KIRBY J SCOTT | Buy | 1.45K | $97.15 | 140.58K |
| 2026-05-14 | Norwalk Leslie V | Buy | 1.45K | $97.15 | 140.58K |
| 2026-05-14 | SANSONE GUY P | Buy | 1.45K | $97.15 | 140.58K |
| 2026-05-14 | DECOUDREAUX ALECIA A | Buy | 1.45K | $97.15 | 140.63K |
| 2026-05-14 | Finucane Anne A. | Buy | 1.54K | $97.15 | 150.00K |
| 2026-05-14 | BROWN C DAVID II | Buy | 1.54K | $97.15 | 150.00K |
| 2026-05-14 | Shulman Douglas H. | Buy | 1.45K | $97.15 | 140.63K |
| 2026-05-14 | ROBBINS LARRY | Buy | 1.93K | $97.15 | 187.50K |
| 2026-05-08 | Mandadi Tilak | Sell | 69.55K | $89.58 | 6.23M |
| 2026-04-01 | Shah Prem S | Sell | 1.48K | $72.49 | 107.58K |
| 2026-04-01 | Nelson Steven H | Sell | 2.43K | $72.49 | 176.30K |
| 2026-04-01 | Mandadi Tilak | Sell | 3.63K | $72.49 | 263.43K |
| 2026-04-01 | Khichi Samrat S. | Sell | 3.54K | $72.49 | 256.69K |
| 2026-04-01 | Joyner J. David | Sell | 8.03K | $72.49 | 582.02K |
| 2026-04-01 | Clark James David | Sell | 3.26K | $72.49 | 236.46K |
| 2026-04-01 | CAPOZZI HEIDI B | Sell | 1.33K | $72.49 | 96.70K |
| 2026-03-31 | Shah Prem S | Buy | 161.68K | $71.82 | 11.61M |
| 2026-03-31 | Shah Prem S | Buy | 25.06K | $71.82 | 1.80M |
| 2026-03-31 | Newman Brian | Buy | 125.75K | $71.82 | 9.03M |
| 2026-03-31 | Newman Brian | Buy | 19.49K | $71.82 | 1.40M |
| 2026-03-31 | Nelson Steven H | Buy | 143.71K | $71.82 | 10.32M |
| 2026-03-31 | Nelson Steven H | Buy | 22.28K | $71.82 | 1.60M |
| 2026-03-31 | Mandadi Tilak | Buy | 143.71K | $71.82 | 10.32M |
| 2026-03-31 | Mandadi Tilak | Buy | 22.28K | $71.82 | 1.60M |
| 2026-03-31 | Khichi Samrat S. | Buy | 80.84K | $71.82 | 5.81M |
| 2026-03-31 | Khichi Samrat S. | Buy | 12.53K | $71.82 | 899.98K |
| 2026-03-31 | Joyner J. David | Buy | 86.33K | $71.82 | 6.20M |
| 2026-03-31 | Compton-Phillips Amy | Buy | 5.57K | $71.82 | 399.97K |
| 2026-03-31 | Compton-Phillips Amy | Buy | 35.93K | $71.82 | 2.58M |
| 2026-03-31 | Clark James David | Buy | 11.14K | $71.82 | 799.93K |
| 2026-03-31 | Clark James David | Buy | 11.98K | $71.82 | 860.12K |
| 2026-03-31 | CAPOZZI HEIDI B | Buy | 10.03K | $71.82 | 720.00K |
| 2026-03-31 | CAPOZZI HEIDI B | Buy | 64.67K | $71.82 | 4.64M |
| 2026-03-19 | Gallina John E | Buy | 582 | $71.86 | 41.82K |
| 2026-03-19 | Gallina John E | Other | 0 | — | — |
| 2026-02-28 | Khichi Samrat S. | Sell | 7.89K | $79.60 | 627.73K |
| 2026-02-28 | Joyner J. David | Sell | 1.94K | $79.90 | 155.33K |
| 2026-01-01 | Shah Prem S | Sell | 247 | $80.13 | 19.79K |
| 2025-12-01 | Clark James David | Sell | 220 | $79.10 | 17.40K |
| 2025-11-30 | Mandadi Tilak | Sell | 6.58K | $80.36 | 528.37K |
| 2025-11-30 | FARAH ROGER N | Sell | 9.75K | $80.36 | 783.35K |
| 2025-11-30 | CAPOZZI HEIDI B | Sell | 9.47K | $80.36 | 761.01K |
| 2025-11-20 | Shulman Douglas H. | Buy | 1.65K | $76.04 | 125.62K |
| 2025-11-20 | SANSONE GUY P | Buy | 1.65K | $76.04 | 125.62K |
| 2025-11-20 | ROBBINS LARRY | Buy | 2.20K | $76.04 | 167.50K |
| 2025-11-20 | Norwalk Leslie V | Buy | 1.65K | $76.04 | 125.62K |
| 2025-11-20 | Mahoney Michael F | Buy | 2.02K | $76.04 | 153.75K |
| 2025-11-20 | KIRBY J SCOTT | Buy | 1.65K | $76.04 | 125.62K |
| 2025-11-20 | Finucane Anne A. | Buy | 1.78K | — | — |
| 2025-11-20 | Finucane Anne A. | Buy | 591 | $76.04 | 44.94K |
| 2025-11-20 | DECOUDREAUX ALECIA A | Buy | 1.65K | — | — |
| 2025-11-20 | BROWN C DAVID II | Buy | 1.77K | $76.04 | 134.97K |
| 2025-11-20 | Balser Jeffrey R. | Buy | 1.77K | $76.04 | 134.97K |
| 2025-11-20 | AGUIRRE FERNANDO | Buy | 1.80K | $76.04 | 136.87K |
| 2025-08-31 | Shah Prem S | Sell | 7.00K | $73.15 | 511.68K |
| 2025-08-31 | Mandadi Tilak | Sell | 12.83K | $73.15 | 938.81K |
| 2025-08-20 | Finucane Anne A. | Sell | 7.50K | $71.02 | 532.65K |
| 2025-06-05 | SANSONE GUY P | Buy | 1.57K | $63.70 | 100.01K |
| 2025-05-31 | Newman Brian | Buy | 94.79K | $64.04 | 6.07M |
| 2025-05-31 | Newman Brian | Buy | 21.86K | $64.04 | 1.40M |
| 2025-05-31 | Compton-Phillips Amy | Buy | 6.25K | $64.04 | 399.99K |
| 2025-05-31 | Compton-Phillips Amy | Buy | 46.84K | $64.04 | 3.00M |
| 2025-05-31 | Compton-Phillips Amy | Buy | 27.08K | $64.04 | 1.73M |
| 2025-05-19 | Compton-Phillips Amy | Other | 0 | — | — |
| 2025-05-19 | Compton-Phillips Amy | Other | 0 | — | — |
| 2025-05-15 | Shulman Douglas H. | Buy | 2.08K | $60.47 | 125.60K |
| 2025-05-15 | SANSONE GUY P | Buy | 2.08K | $60.47 | 125.60K |
| 2025-05-15 | ROBBINS LARRY | Buy | 2.77K | — | — |
| 2025-05-15 | Norwalk Leslie V | Buy | 2.08K | $60.47 | 125.60K |
| 2025-05-15 | Mahoney Michael F | Buy | 144 | $60.47 | 8.71K |
| 2025-05-15 | Mahoney Michael F | Buy | 2.54K | — | — |
| 2025-05-15 | KIRBY J SCOTT | Buy | 2.77K | $60.47 | 167.44K |
| 2025-05-15 | Finucane Anne A. | Buy | 2.08K | — | — |
| 2025-05-15 | Finucane Anne A. | Buy | 692 | $60.47 | 41.85K |
| 2025-05-15 | DECOUDREAUX ALECIA A | Buy | 2.08K | — | — |
| 2025-05-15 | BROWN C DAVID II | Buy | 2.23K | $60.47 | 134.97K |
| 2025-05-15 | Balser Jeffrey R. | Buy | 2.23K | $60.47 | 134.97K |
| 2025-05-15 | AGUIRRE FERNANDO | Buy | 2.26K | $60.47 | 136.84K |
| 2025-05-12 | Newman Brian | Other | 0 | — | — |
| 2025-05-12 | Newman Brian | Other | 0 | — | — |
| 2025-05-12 | Newman Brian | Other | 0 | — | — |
| 2025-05-06 | ROBBINS LARRY | Sell | 150.00K | $66.67 | 10.00M |
| 2025-05-05 | ROBBINS LARRY | Sell | 1.23M | $67.37 | 82.65M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 2.17K, holders +204 vs prior quarter. Ownership 90.25%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 123.22M | -2.70M | -2.14% | 12.75B |
| VANGUARD CAPITAL MANAGEMENT LLC | 83.32M | 665.29K | +0.80% | 8.62B |
| CAPITAL WORLD INVESTORS | 74.95M | -2.30M | -2.97% | 7.75B |
| STATE STREET CORP | 60.28M | 961.23K | +1.62% | 6.24B |
| DODGE & COX | 50.01M | -1.77M | -3.41% | 5.17B |
| WELLINGTON MANAGEMENT GROUP LLP | 33.80M | 11.23M | +49.78% | 3.50B |
| GEODE CAPITAL MANAGEMENT, LLC | 29.90M | 440.61K | +1.50% | 3.08B |
| FMR LLC | 28.92M | -2.28M | -7.30% | 2.99B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26.64M | 639.91K | +2.46% | 2.76B |
| CAPITAL RESEARCH GLOBAL INVESTORS | 24.33M | 4.32M | +21.57% | 2.52B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 24.20M | 420.74K | +1.77% | 2.50B |
| BANK OF AMERICA CORP /DE/ | 23.19M | 13.84M | +147.95% | 2.40B |
| JPMORGAN CHASE & CO | 22.11M | -7.41M | -25.11% | 2.29B |
| INVESCO LTD. | 20.60M | -4.54M | -18.07% | 2.13B |
| MORGAN STANLEY | 18.61M | 780.91K | +4.38% | 1.92B |
| NORGES BANK | 18.04M | 18.04M | New | 1.87B |
| CAPITAL INTERNATIONAL INVESTORS | 15.39M | -4.62K | -0.03% | 1.59B |
| GOLDMAN SACHS GROUP INC | 13.41M | 11.79M | +728.20% | 1.39B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13.26M | -415.61K | -3.04% | 1.37B |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 13.26M | 13.26M | New | 1.37B |
| DAVIS SELECTED ADVISERS | 11.87M | -373.75K | -3.05% | 1.23B |
| PZENA INVESTMENT MANAGEMENT LLC | 11.77M | -2.00M | -14.55% | 1.22B |
| NORTHERN TRUST CORP | 11.47M | -169.72K | -1.46% | 1.19B |
| FRANKLIN TEMPLETON INC | 9.99M | 3.74M | +59.98% | 1.03B |
| LEGAL & GENERAL GROUP PLC | 9.17M | -342.72K | -3.60% | 948.95M |
Insights
- Revenue by product
| Period | Value |
|---|---|
| FY2010 | Intersegment Eliminations: -8712000000.0, Pharmacy Services Segment: 47780000000.0, Retail Pharmacy Segment: 57345000000.0 |
| FY2011 | Intersegment Eliminations: -11373000000.0, Pharmacy Services Segment: 58874000000.0 |
| FY2012 | Intersegment Eliminations: 3400000000.0, Pharmacy Services Segment: 73444000000.0 |
| FY2013 | Intersegment Eliminations: -15065000000.0, Pharmacy Services Segment: 76208000000.0, Retail Pharmacy Segment: 65618000000.0 |
| FY2014 | Intersegment Eliminations: -16871000000.0, Pharmacy Services Segment: 88440000000.0, Retail Pharmacy Segment: 67798000000.0 |
| FY2015 | Intersegment Eliminations: -19080000000.0, Pharmacy Services Segment: 100363000000.0, Retail Pharmacy Segment: 72007000000.0 |
| FY2016 | Intersegment Eliminations: -23537000000.0, Pharmacy Services Segment: 119963000000.0, Retail Pharmacy Segment: 81100000000.0 |
| FY2017 | Intersegment Eliminations: -25229000000.0, Pharmacy Services Segment: 130596000000.0, Retail Pharmacy Segment: 79398000000.0 |
| FY2018 | Front Store Revenue: 19055000000.0, Pharmacy Revenue: 164845000000.0, Premiums: 8184000000.0 |
| FY2019 | Front Store Revenue: 19422000000.0, Pharmacy Revenue: 165899000000.0, Premiums: 63122000000.0, Product and Service, Other: 7322000000.0 |
| FY2020 | Front Store Revenue: 19655000000.0, Pharmacy Revenue: 171289000000.0, Premiums: 69364000000.0, Product and Service, Other: 7600000000.0 |
| FY2021 | Front Store Revenue: 21315000000.0, Pharmacy Revenue: 184618000000.0, Premiums: 76132000000.0, Product and Service, Other: 8847000000.0 |
| FY2022 | Front Store Revenue: 22780000000.0, Pharmacy Revenue: 205121000000.0, Premiums: 85330000000.0, Product and Service, Other: 8398000000.0 |
| FY2023 | Front Store Revenue: 22458000000.0, Pharmacy Revenue: 223452000000.0, Premiums: 99192000000.0, Product and Service, Other: 11521000000.0 |
| FY2024 | Front Store Revenue: 21522000000.0, Pharmacy Revenue: 210272000000.0, Premiums: 122896000000.0, Product and Service, Other: 15966000000.0 |
| FY2025 | Front Store Revenue: 21459000000.0, Pharmacy Revenue: 229025000000.0, Premiums: 134751000000.0, Product and Service, Other: 3926000000.0 |
Insights · Dividends · Forecast · Financials · Learn